Rigel Pharmaceuticals (RIGL) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -44.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.57% |
| Dec 31, 2025 | -13.73% |
| Sep 30, 2025 | -56.44% |
| Jun 30, 2025 | 44.94% |
| Mar 31, 2025 | -57.32% |
| Dec 31, 2024 | 34.61% |
| Sep 30, 2024 | 31.76% |
| Jun 30, 2024 | -45.51% |
| Mar 31, 2024 | 11.28% |
| Dec 31, 2023 | -26.80% |
| Sep 30, 2023 | -232.24% |
| Jun 30, 2023 | 43.80% |
| Mar 31, 2023 | -11.33% |
| Dec 31, 2022 | 31.16% |
| Sep 30, 2022 | 36.06% |
| Jun 30, 2022 | 27.71% |
| Mar 31, 2022 | 77.16% |
| Dec 31, 2021 | -40.54% |
| Sep 30, 2021 | -147.44% |
| Jun 30, 2021 | 37.43% |
| Mar 31, 2021 | -96.84% |
| Dec 31, 2020 | -35.70% |
| Sep 30, 2020 | 26.30% |
| Jun 30, 2020 | -5.05% |
| Mar 31, 2020 | 0.28% |
| Dec 31, 2019 | -25.83% |
| Sep 30, 2019 | -92.34% |
| Jun 30, 2019 | -69.31% |
| Mar 31, 2019 | 61.81% |
| Dec 31, 2018 | 44.88% |
| Sep 30, 2018 | -29.44% |
| Jun 30, 2018 | 43.92% |
| Mar 31, 2018 | -59.45% |
| Dec 31, 2017 | 73.19% |
| Sep 30, 2017 | 15.36% |
| Jun 30, 2017 | -41.64% |
| Mar 31, 2017 | 79.54% |
| Dec 31, 2016 | -55.01% |
| Sep 30, 2016 | 29.51% |
| Jun 30, 2016 | 41.18% |
| Mar 31, 2016 | -256.32% |
| Dec 31, 2015 | -9.96% |
| Sep 30, 2015 | 219.94% |
| Jun 30, 2015 | -101.45% |
| Mar 31, 2015 | 100.77% |
| Dec 31, 2014 | 270.25% |
| Sep 30, 2014 | 23.03% |
| Jun 30, 2014 | -19.57% |
| Mar 31, 2014 | -33.01% |
| Dec 31, 2013 | 33.25% |
| Sep 30, 2013 | 16.90% |